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Abstract
Although functional recovery could be advocated as an achievable treatment goal, many effective interventions for 
the treatment of psychotic symptoms, such as antipsychotic drugs, may not improve functioning. The last two decades 
of cognitive and clinical research on schizophrenia were a turning point for the firm acknowledgment of how relevant 
social cognitive deficits and negative symptoms could be in predicting psychosocial functioning. The relevance of so-
cial cognition dysfunction in schizophrenia patients’ daily living is now unabated. In fact, social cognition deficits could 
be the most significant predictor of functionality in patients with schizophrenia, non-redundantly with neurocogni-
tion. Emerging evidence suggests that negative symptoms appear to play an indirect role, mediating the relationship 
between neurocognition and social cognition with functional outcomes. Further explorations of this mediating role 
of negative symptoms have revealed that motivational deficits appear to be particularly important in explaining the 
relationship between both neurocognitive and social cognitive dysfunction and functional outcomes in schizophrenia. 
In this paper we will address the relative contribution of two key constructs—social cognitive deficits and negative 
symptoms, namely how intertwined they could be in daily life functioning of patients with schizophrenia. 
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Introduction
In Eugene Bleuler’s seminal works on schizophrenia, near-
ly a century ago, it was clear that he had a perceptive un-
derstanding of cognitive impairment as a core part of this 
psychotic disorder; that was consubstantiated in the defini-
tion of his fundamental symptoms—substantially cognitive 
in their essence, yet distinguished from what was observed 
in organic dementias [1,2]. Nonetheless, modern diagnos-
tic criteria on schizophrenia have relied heavily on positive 
symptoms, based on the prescient contributions of other 
authors such as Emil Kraeplin and Kurt Schneider. Despite 
the appearance, in the 1950s, of the first antipsychotics, 
followed by subsequent and more effective pharmaco-
logical therapies, a considerable number of patients with 
schizophrenia still face substantial difficulties in fulfilling 
normative social and occupational roles. The last two de-
cades of cognitive and clinical research on schizophrenia 
were a turning point for the firm acknowledgment of how 
relevant social cognitive deficits and negative symptoms 
could be in predicting psychosocial functioning.
Given that the 5th Edition of the Diagnostic and Sta-
tistical Manual of Mental Disorders—DSM-5—requires 
deterioration of psychosocial functioning (including social 
activities, personal and social relationships, and self-care) 
to make a diagnosis of schizophrenia, it came as no sur-
prise that functional outcomes have somehow surpassed 
clinical remission goals in measuring success of interven-
tions and mental health care in patients with psychosis [3]. 
Nonetheless, although functional recovery could be advo-
cated as an achievable treatment goal, many effective in-
terventions for the treatment of psychotic symptoms, such 
as antipsychotic drugs, may not improve functioning [4]. 
In this paper we will address the relative contribution of 
two key constructs—social cognitive deficits and negative 
symptoms, namely how intertwined they could be in daily 
life functioning of patients with schizophrenia.
Social cognition
Social cognition refers to the psychological processes in-
volved in the perception, encoding, storage, retrieval, and 
regulation of information about others and ourselves: social 
cue perception, experience sharing, inferring other people’s 
thoughts and emotions, and managing emotional reactions 
to others [5]. Social cognition became one of the major ar-
eas of research interest in schizophrenia because it has been 
identified as one of the most important predictors of func-
tional outcome [6,7]. Individuals with schizophrenia often 
present marked impairments in processing social informa-
tion, which results in misinterpretations of the social in-
tent of others, social withdrawal, and impaired daily social 
functioning [8,9]. Over the past few years we have seen an 
increased research interest concerning the relationships be-
tween social cognition and functioning due to three major 
reasons. First, research has indicated that these deficits are 
separable from those of neurocognition [10]. On the other 
hand, these deficits have strong and independent relation-
ships to functional outcomes [8]. Lastly, emerging research 
suggests that these deficits may be more proximal to some 
dimensions of functional outcomes than deficits in neuro-
cognition. In this regard, Schmidt et al. demonstrated that 
social cognition served in many cases as a robust mediator 
of the relationship between neurocognition and function-
al outcome [11]. Thus, social cognition has been identified 
as a crucially important area of research in schizophrenia; 
as a means of exploring both the interpersonal difficulties 
experienced by individuals with this illness, as well as the 
consequences of these difficulties, such as poorer vocational 
outcomes, a lack of community participation and indepen-
dence, and limitations in the formation and maintenance of 
close emotional relationships [6]. Deficits in social cognition 
are well evidenced in schizophrenia, both in the established 
illness [12] and prior to illness onset [9,13], suggesting that 
they are relatively stable [14]. Thus, an understanding of 
social cognitive impairments in schizophrenia may provide 
opportunities for targeted recovery-focused interventions 
[15]. Studies of social cognition in schizophrenia may also 
provide more general insight into the mechanisms under-
lying the disorder, as these impairments have trait-like 
qualities that precede the onset of illness and are candidate 
endophenotypes [16,17].
Dimensions of social cognition: impairments in 
schizophrenia
From a conceptual point of view, taking into account orga-
nizational models of neural systems in social neuroscienc-
es, we can identify four general social cognitive processes: 
perception of social cues, experience sharing, mentalizing, 
and experiencing and emotion regulation [5].
Perception of social cues
In interpersonal contexts, individuals encounter a diverse 
array of social cues from other’s faces, voices, and body 
movements (gait, posture, gestures). In schizophrenia, 
studies of social cue perception have focused on the per-
ception of faces and voices.
Studies of non-affective face processing have shown 
that patients with schizophrenia and healthy controls show 
comparable performance in age and sex discriminations 
tasks, but patients have difficulty in matching and discrim-
inating the identity of individuals [18]. Studies concern-
ing affective face processing are more consistent and have 
shown that patients demonstrate lower activation in brain 
regions associated with affective face perception but they 
show increased activation in areas not associated with face 
perception [19]. Patients may, therefore, recruit alternative 
areas to compensate for dysfunction in the key face emo-
tion processing regions.
Vocal perception of social relevant cues refers to the 
acoustic properties of speech (pitch, intonation and rhythm; 
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also called prosody), including emphasis and emotional 
tone, that provides critical information beyond the meaning 
of words. Most studies of voice perception in individuals 
with schizophrenia have investigated affective prosody. Af-
fective prosody perception has been examined using tasks of 
implicit and explicit processing: listening to sentences read 
with and without emotional intonation or making emo-
tional judgments about a sentence read with and without 
emotional intonation. Findings of non-affective prosody in 
schizophrenia are mixed: patients did not differ from con-
trols when discriminating intonation of sentences [20], but 
showed deficits in discriminating pitch and rhythm of voice 
stimuli [21]. Regarding affective prosody perception, stud-
ies have shown consistent behavioral impairment and lower 
activation in key regions, for example, the superior tempo-
ral gyrus and the inferior frontal gyrus [22].
Experience sharing
Observation of another person’s behavior triggers neural 
activity in the brain regions that become activated when 
engaging in that behavior oneself. It is thought that vicar-
ious neural activation during experience sharing directly 
facilitates understanding of the mental states of others 
[23]. Experience sharing could be separated into two pro-
cesses with different functions and partly distinct neural 
substrates: motor resonance and affect sharing [24].
Motor resonance refers to a functional correspondence 
between the state in the motor system of an observer and 
that in the motor system of the person making the action 
[25]. Studies of motor resonance using fMRI in schizophre-
nia have provided mixed results [26]. However, it should be 
noted that this area of research is still new and the scientific 
approaches used are diverse, which may account for some 
of the discrepancies in available evidence [6].
Affect sharing refers to the functional correspondence 
between the observation of a person who is displaying an 
emotional expression and the activation of emotion-relat-
ed brain regions of the observer. The available evidence 
suggests that this subprocess is intact. In self-report stud-
ies, patients score similarly to healthy controls for personal 
traits associated with affect sharing and some of them sug-
gest a tendency to be overly sensitive and reactive to the 
feelings of others compared with healthy controls [27]. To 
date, only one study has used fMRI to study affect sharing 
in these patients: although imitation and execution of emo-
tional expressions were impaired in patients, both groups 
showed similar levels of activation in regions associated 
with affect sharing, including inferior prefrontal, premo-
tor, and inferior and superior parietal cortices [28].
Mentalizing 
To understand the behavior of others in a social environ-
ment, it is often necessary to take other people’s view-
points into account and to make inferences about the men-
tal states of others based on available social cues and social 
context. This ability to infer the mental states of other 
people (including their intentions, beliefs and emotions) is 
called mentalizing, also known as theory of mind or mental 
state attribution [29].
Brain regions associated with mentalizing have been 
studied using a wide range of paradigms: simple written 
stories about people interacting, cartoon panels depicting 
people interacting, or pictures showing only the eye region 
of the face, and asking the participants to infer the beliefs, 
intentions or emotions of the people depicted in these sto-
ries, cartoons or pictures [30]. Meta-analyses indicate that 
patients with schizophrenia have difficulty understanding 
the intentions of others from a cartoon panel and inferring 
the beliefs of others from simple written stories [31,32]. 
These patients show aberrant neural activation in brain 
regions associated with mentalizing when they are asked 
to infer the mental states of others. However, the reported 
changes are not consistent across studies. Most studies de-
scribe lower  activation of the core mentalizing system and 
impaired mentalizing ability in behavioral tasks [33-35]. 
A few studies found increased activation of brain regions 
associated with mentalizing [36,37] leading to the hypoth-
esis that individuals with schizophrenia may need great-
er activation in these regions to achieve the same level of 
mentalizing proficiency, suggesting neural inefficiency. It 
was proposed that positive symptoms are linked to hyper-
mentalizing and negative symptoms to hypomentalizing; 
positive symptoms should result in a pattern of additional 
emotion and intention attributions to other people, while 
negative symptoms should result in a lack of emotion and 
intention attributions [38].
The findings of increased neural activity in mentaliz-
ing regions and results of behavioural studies fit with the 
tendency of some individuals with schizophrenia to over- 
attribute intention to others and to perceive (negative) 
emotions in stimuli that are emotionally neutral. This ten-
dency, called hypermentalizing, has been linked to paranoid 
symptoms of schizophrenia [39].
Emotion experience and regulation 
The emotional reactions to others and how an individu-
al deals with these reactions determines the adaptive re-
sponse to the complexities of social environment. Two 
aspects of emotion processing, emotion experience and 
emotion regulation, have received the most attention in 
schizophrenia [5].
Emotion experience refers to the immediate emotional 
responses induced by pleasant or unpleasant stimuli. It has 
been demonstrated that in schizophrenia emotion experi-
ence is largely intact during exposure to pleasant stimuli 
and that emotion experience is also normal or, in some con-
texts, heightened in response to unpleasant stimuli [40,41]. 
Control over emotion is thought in terms of a dynamic 
interplay between two processes: emotion generation and 
emotion regulation [42]. Most studies using self-report 
measures have shown that individuals with schizophrenia 
use cognitive reappraisal less frequently than do healthy 
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Test [29], Silent Animations [55], The Awareness of So-
cial Inference Test (TASIT) [56], The Hinting Task [57], 
Visual Perspective Tasking Task [58]. The final measures 
integrating the SCOPE study were Reading the Mind in the 
Eyes Test, The Awareness of Social Inferences Test—part 
III and The Hinting Task [7]. 
Emotion processing is broadly defined as perceiving and 
using emotions [17]. It subsumes three domains that repre-
sent both lower level and higher level processes. At a lower 
perceptual level is the first subdomain emotion perception/
recognition (identifying and recognizing emotional dis-
plays from facial expressions and/or nonface cues such as 
voice). At a higher level we have the two subdomains of 
understanding emotions and managing emotions. Some of 
the instruments studied in this field are: Bell Lysaker Emo-
tion Recognition Task (BLERT) [59], Diagnostic Analysis 
of Nonverbal Accuracy 2 (DANVA2) [60], Face Emotion 
Discrimination Test (FEDT) [61], Penn Emotion Recogni-
tion Task (ER-40) [62]. The Bell Lysaker Emotion Recog-
nition Task and the Penn Emotion Recognition Test were 
the chosen measures in SCOPE study [7].
Social perception refers to decoding and interpret-
ing social cues in others [63,65]. It includes social context 
processing and social knowledge, which can be defined 
as knowing social rules, roles, and goals (RRGs), utilizing 
those RRGs, and understanding how such RRGs may in-
fluence others’ behaviors [66,67]. Assessing this domain 
of social cognition has used diverse measures such as: Half 
Profile of Nonverbal Sensitivity (Half PONS) [68], Inter-
personal Perception Task (IPT-15) [69], and Relationships 
Across Domains (RAD) [70], which was the test chosen to 
integrate the final SCOPE battery [7].
Attributional style or bias describes the way in which 
individuals explain the causes, or make sense, of social 
events or interactions [17,49]. The Ambiguous Intentions 
and Hostility Questionnaire (AIHQ) [71] and the Internal, 
Personal, and Situational Attributions Questionnaire (IP-
SAQ) [72] are the most used tasks assessing attributional 
style. The Ambiguous Intentions and Hostility Question-
naire is the final task considered in the SCOPE study [7].
As part of the Social Cognition Psychometric Evalua-
tion (SCOPE) study, the psychometric properties of 8 tasks 
were assessed in a sample of one hundred and seventy-nine 
stable outpatients with schizophrenia and 104 healthy 
controls, who completed the battery at baseline and a re-
test 2–4-weeks later, at 2 sites. Tasks included the AIHQ, 
BLERT, ER-40, RAD, Reading the Mind in the Eyes Test, 
TASIT, Hinting Task, and Trustworthiness Task. Tasks 
were evaluated on: (i) test-retest reliability, (ii) utility as a 
repeated measure, (iii) relationship to functional outcome, 
(iv) practicality and tolerability, (v) sensitivity to group 
differences, and (vi) internal consistency. The BLERT and 
Hinting task showed the strongest psychometric properties 
across all evaluation criteria and are recommended for use 
in clinical trials. The ER-40, Eyes Task, and TASIT showed 
somewhat weaker psychometric properties and require 
individuals, and that lower use of this process is associated 
with poor outcomes in community functioning and more 
severe clinical symptoms [43]. Evidence suggests that the 
use of cognitive-reappraisal strategies is disrupted in schizo-
phrenia [44,45], which is consistent with the neural impair-
ments in cognitive control processes in this disorder [46].
We can summarize these findings by stating that there 
is strong evidence to suggest that people with schizophre-
nia have impairments in some, but not all, social cogni-
tive processes. There is consistent evidence suggesting 
schizophrenia is associated with impairments in facial and 
prosody perception, mentalizing, and emotion regulation. 
Conversely, the findings regarding emotion experience in 
schizophrenia suggest that this process is largely intact [40]. 
Furthermore, some evidence shows that motor resonance 
and affect sharing are intact in schizophrenia. However, it 
is important to note that a few studies on experience shar-
ing and some of the findings are contradictory. To date, the 
available data suggest that any impairment in experience 
sharing may be subtle. Lastly, it is important to underline 
some of the limitations of the findings on social cognitive 
impairment in schizophrenia: most of the studies included 
samples in which the majority of patients were medicated 
and the individuals involved were predominantly male [5]. 
Measuring social cognition in schizophrenia
From an empirical point of view, an National Institute of 
Mental Health's (NIMH) consensus statement, generated 
from a convention of leading social cognitive researchers, 
recognized theory of mind, emotion perception/process-
ing, attributional style, social perception, and social knowl-
edge as representing the major domains of social cognition 
[17]. Penn and colleagues [12] similarly identified theory 
of mind, emotion perception, and attributional style as be-
ing particularly salient for individuals with schizophrenia, 
who consistently demonstrate impaired social cognitive 
abilities in each of these areas [31,47,48]. The Social Cog-
nition Psychometric Evaluation (SCOPE) study [7], de-
signed to achieve a consensus on the key domains of social 
cognition schizophrenia, identified four major domains: 
1) theory of mind (ToM) or the ability to attribute beliefs 
and intentions; 2) emotion processing (prosodic and facial) 
or the ability to recognize other people’s feelings from ei-
ther facial expressions or vocal inflections and use them to 
guide behaviors; 3) social perception and knowledge or the 
ability to judge and be aware of cues and rules that occur 
is social situations; and 4) attributional style or bias, which 
refers to an individual’s tendency to attribute the cause of 
an event to either oneself, others or the environment.
ToM is defined as the ability to represent the mental 
states of others including the inference of intentions, dis-
positions, and/or beliefs [49,50]. This ability is also re-
ferred to as mentalizing, mental state attribution, or cog-
nitive empathy [51]. Research in this field has used tasks 
like: Adult Faux Pas [52], Brune Picture Sequencing Task 
[53], Happe’s Stories [54], Reading the Mind in the Eyes 
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further study. The AIHQ, RAD, and Trustworthiness Task 
showed poorer psychometric properties [48].
Empathy impairment in schizophrenia—an 
integrated model of social cognition
Impairments in social processing may emerge within a net-
work, when components of the network need to interact 
with each other, or between networks, when higher-level 
integration is needed [5]. Empathy refers to sharing, un-
derstanding and responding to the emotional experiences 
of another person, depending on multiple components of 
social cognition and is viewed as an example of integration 
among social processing systems [51,73]. Both experience 
sharing and mentalizing are included in most models of 
empathy [24,51], and some models also emphasize the role 
of emotion regulation as a way to modulate an empathic 
response when it becomes maladaptive [74]. It was shown 
that patients with schizophrenia have impairments in mon-
itoring the emotions of others, suggesting that they do ex-
hibit problems in complex social-cognitive abilities such as 
empathy [75,76]. Studies on empathy reveal that patients 
with schizophrenia are impaired in this cognitive domain, 
but unaffected with regard to the affective domain [76], a 
pattern comparable to recent findings in autism [77]. These 
empathic accuracy deficits in schizophrenia are likely to be-
gin with impaired perception of social information and il-
lustrate how integration among social cognitive processing 
systems is essential for adaptive social interactions [5].
Negative symptoms: evolution of the concept
Negative symptoms have been regarded as a core feature of 
Schizophrenia since the seminal descriptions of Emil Krae-
pelin and Eugen Bleuler, whose observations underlined 
the key role of volitional and affective disturbances in the 
course of the disorder [78]. However, the term "Negative 
Symptoms" was only introduced in psychiatry when John 
Hughlings Jackson conceptualized these symptoms as the 
core lesion of the disease, reflecting a loss of normal function 
and "dissolution of neural arrangements”. In turn, Jackson 
attributed the emergence of positive symptoms to a loss of 
top-down inhibitory activity [79,80].
The discovery of antipsychotic drugs and their efficacy 
on positive symptoms posed excessive attention on this lat-
ter symptom domain. Nonetheless, the importance of neg-
ative symptoms continued to be recognized. Thus, in the
1980s, Andreasen [81] introduced a new conceptual-
ization, emphasizing affective flattening and alogia, among 
other symptoms like avolition, apathy, anhedonia and 
asociality, also included in the construct [78]. Moreover, 
Crow's proposal of  "Type I and Type II Schizophrenia" 
[82] was based on the preponderance of negative symp-
toms over positive symptoms. Importantly, Carpenter et 
al. [83] distinguished between primary negative symptoms, 
inherent to the disease process itself and secondary negative 
symptoms that could be a medication side-effect, a reaction 
to the illness or its associated deprivations, or responses to 
other symptoms, such as withdrawal secondary to paranoia 
[79]. It has been suggested that a “deficit syndrome” associ-
ated with a particularly poor outcome and predominately 
entailing primary and persistent negative symptoms can be 
found in 15% of first-episode patients and in approximately 
a third of cases of chronic schizophrenia [84,85].
The impact of negative symptoms on outcomes in 
Schizophrenia, and the lack of effective treatments, has 
driven the NIMH to develop a consensus definition of neg-
ative symptoms in Schizophrenia which has included symp-
toms of affective flattening, alogia, avolition, asociality, and 
anhedonia [86]. Although a considerable overlap exists be-
tween the NIMH consensus definition and Andreasen's his-
torical definition [81], factor analysis studies have shown 
that symptoms of inattention, poverty of content in speech 
and inappropriate affect are more in line with the disorga-
nization than with the negative symptoms domain [87,88]. 
Moving beyond the definition itself, studies investi-
gating the factor structure of the construct [87-90] have 
revealed that negative symptoms usually cohere into two 
distinct, yet related, subdomains: diminished expression, 
consisting of affective flattening and poverty of speech; and 
amotivation, consisting of avolition, apathy, asociality, and 
hedonic deficits. In addition, recent research has been fo-
cusing in further refining the negative symptom construct, 
with the majority of studies exploring the anhedonia and 
amotivation symptom domain. In short, the available evi-
dence demonstrates that people with schizophrenia report 
levels of in-the-moment positive emotion and subjective 
arousal similar to healthy controls when exposed to pleas-
ant stimuli but present an anticipatory pleasure deficit, or 
alternatively “reduced pleasure-seeking behavior” and “be-
liefs of low pleasure” [79,91]. In what concerns to motiva-
tion, research has identified underlying deficits in reward 
learning, reward prediction, update of internal value rep-
resentations, and impairments using this information to 
guide motivated behavior [91-93].
Negative symptoms and psychosocial 
functioning
Negative symptoms are well established predictors of poor 
functional outcome in schizophrenia [84,94,95], this being 
true whether we consider impairments in socially useful 
activities, personal and social relationships, activities relat-
ed to one's self-care [4] or decreased quality of life [96]. 
Negative symptoms are common and long lasting: their 
prevalence in short-term follow-up studies (up to 2.5 years) 
is about 45%, and in longer term studies (7.5–10 years) 
20–30% [97].The deleterious impact of negative symptoms 
on functional performance has been shown to be present 
throughout the lifespan of schizophrenia and not only in 
medicated, chronic, remitting-relapsing subjects [85]. Ac-
cordingly, in the early stages of the disease, at the first-ep-
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isode [89] and during the proceeding years [98,99], the 
presence of this symptom cluster is one of the greatest bar-
riers to the achievement of functional recovery. Moreover, 
before full blown psychosis occurs, during the so-called 
high-risk (HR) or prodromal state, negative symptoms 
and impaired social cognition have been associated with 
marked impairment in psychosocial function [100,101] 
which appears to be a core feature of the HR state and 
tends to be resistant to all types of treatment [102]. The 
presence of negative symptoms of “avolition” and “poor 
emotional expression” in the prodrome is in agreement 
with the notion of their primary nature and suggests that 
negative symptoms and their neural substrates may even 
be a driver (like impaired social cognition) of transition 
to psychosis [85]. In fact, there is evidence that negative 
symptoms rather than positive symptoms can significantly 
impact the transition from a HR state to frank psychosis 
and its long-term outcomes [103,104]. 
Research has yielded insights on the impact of each of 
the two independent subdomains (“amotivation” and “poor 
emotional expression”) of negative symptoms on func-
tional outcomes in schizophrenia [94]. Accordingly, the 
amotivation subdomain of negative symptoms has demon-
strated significant relationship to functional outcomes in 
schizophrenia, including instrumental role performance, 
household adjustment, extended family functioning, and 
social/leisure functioning [105]. In line with this, several 
studies examined the prevalence of motivational deficits in 
patients throughout the different stages of the illness, and 
the impact these deficits have on psychosocial functioning, 
both cross-sectionally and longitudinally. Current research 
into the determinants of social functioning impairments 
in HR individuals suggests that motivational impairment 
is more important in determining level of social function-
ing relative to expression symptoms of affective flattening 
and alogia [101]. Correspondingly, it may be hypothesized 
that treatments alleviating negative symptoms in HR young 
subjects would both alleviate suffering and reduce the risk 
of transition to schizophrenia [85,102].
Motivational deficits are common in first episode psy-
chosis (FEP) and have been shown to persist significantly in 
long-term. In the TIPS (Early Treatment and Intervention 
in Psychosis) FEP cohort, 30% of patients showed clinical 
levels of apathy when assessed ten years after the first psy-
chotic episode and its presence was related to impaired func-
tioning and poorer subjective quality of life [106].
The prevalence of motivational deficits in patients ear-
ly in the illness (within 5 years of initiating antipsychotic 
treatment) and the impact these deficits have on commu-
nity functioning have been also examined. Fervaha et al. 
[98] found that motivational impairments were present 
in more than 75% of patients. These deficits served as the 
most robust and reliable predictor of functional outcome in 
early-course patients even after selected demographic and 
clinical characteristics (e.g., positive symptoms) were ac-
counted for. Finally, in studies designed to identify predic-
tors of real-life functioning in people with chronic schizo-
phrenia, avolition had both a direct [94,107] and an indirect 
relationship real-life functioning [94,105]. In those studies, 
avolition was an independent domain with respect to both 
neurocognition and social cognition suggesting that the 
search for treatments with an impact on this domain should 
be a priority of mental health research strategies. 
Within the motivational domain of negative symptoms, 
the relationship between anhedonia and functional out-
comes has also received considerable attention with con-
flicting results: anhedonia has correlated with functional 
outcomes in some studies but not in other [79]. 
Findings regarding a relationship between the dimin-
ished expression subdomain of negative symptoms and 
functional outcomes in schizophrenia have been mixed, 
with a relationship found in one study [108] but not in oth-
ers, particularly after accounting for the predictive role of 
amotivation [105,109]. 
It was recently been suggested that different negative 
symptoms correlate with different functional outcomes: 
expression-related symptoms predicted social competence 
while symptoms reflecting social amotivation were directly 
correlated with everyday social outcomes [107]. In addition, 
motivational deficits also appear to play an indirect role, 
partially mediating the relationship between neurocogni-
tion and social cognition with functional outcomes [79].
Overall, the available evidence indicates that motiva-
tional deficits are a key predictor of functional impairment 
beyond the impact of other negative symptoms not only 
in individuals with chronic schizophrenia but also at the 
early stages of the disease. This underscores the need to 
better understand the underlying mechanisms of motiva-
tional deficits [92,93] in order to provide the opportunity 
to personalize treatment and therefore establish effective 
interventions that will curb longer-term poor functioning 
[98]. In agreement, such interventions may benefit from 
focusing on strategies to enhance engagement in one's life, 
increasing goal-directed behavior, supporting greater effort 
expenditure, and harnessing intact consummatory pleasure 
to improve quality of life [101].
The interplay of negative symptoms with deficits 
in social cognition
The interplay between negative symptoms and social cog-
nition in terms of phenotype, underlying neurobiological 
substrates and potential treatment strategies is a complex 
and unresolved matter since, while distinct, these two con-
structs interact. As described in the previous sections, both 
negative symptoms and impaired social cognition exert a 
deleterious impact on functional outcomes. The emerg-
ing evidence suggests that social cognition drives negative 
symptoms which, in turn, may play an indirect role, medi-
ating the relationship between social cognition with func-
tional outcomes [9,110,111]. Further explorations of this 
mediating role of negative symptoms have revealed that 
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motivational deficits appear to be particularly important in 
explaining the relationship between both neurocognitive 
and social cognitive dysfunction with functional outcomes 
in schizophrenia [9, 79, 98]. This cross-talk between social 
cognition impairment and negative symptoms is unsur-
prising since they share several underlying neurobiologi-
cal substrates, namely the temporal cortex (including the 
superior temporal gyrus) and the prefrontal cortex (PFC) 
[112]. Another example of this interrelationship is that 
social withdrawal is both a feature of negative symptoms 
and a consequence of faulty social cognition. On the other 
hand, a lack of motivation to engage in social contact rein-
forces deficits in social cognition [85].  The key issue is that 
deficits in social cognition not only worsen positive symp-
toms, but also contribute to and drive negative symptoms. 
Therefore, improving social outcomes seems to require a 
multi-faceted approach which considers social cognition 
and negative symptoms.
Concluding remarks
Despite earlier formulations that established poor prog-
nosis as a key criterion in the definition of schizophrenia, 
long-term follow-up studies have demonstrated a diversity 
of patterns in terms of course and prognosis, including good 
outcome, as in Manfred Bleuler’s (Eugene’s son) enduring 
follow-up of more than 200 patients with schizophrenia at 
the Burghölzli Hospital [113,114]. Nonetheless, individuals 
with schizophrenia frequently have significant difficulties 
in life functioning; as many as two-thirds of schizophrenia 
patients are unable to accomplish psychosocial roles, even 
when psychotic symptoms are in remission [115,116].
The relevance of social cognition dysfunction in schiz-
ophrenia patients’ daily living is now unabated. Extensive 
research on this subject has brought some light to aspects 
such as its neural basis, but most of all focusing on this do-
main as a potential therapeutic target [117]. In fact, social 
cognition deficits could be the most significant predictor of 
functionality in patients with schizophrenia, non-redun-
dantly with neurocognition [6]. 
The emerging evidence suggests that negative symp-
toms appear to play an indirect role, mediating the rela-
tionship between neurocognition and social cognition 
with functional outcomes [79,98] Further explorations of 
this mediating role of negative symptoms have revealed 
that motivational deficits appear to be particularly impor-
tant in explaining the relationship between both neuro-
cognitive and social cognitive dysfunction and functional 
outcomes in schizophrenia [9]. 
A recent investigation (the North American Prodrome 
Longitudinal Study) on clinically high-risk (CHR) patients 
for psychosis reported that negative symptoms mediated 
the relationship between composite neurocognition and 
social and role functioning; such findings replicate what 
a previous meta-analysis of schizophrenia studies had re-
ported [118,119]. Nonetheless, the modest overlap among 
neurocognition, negative symptoms, and social function-
ing suggests that these domains make substantially sepa-
rate contributions to the outcome in CHR patients [118].
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